Core Points - Nanjing Novogene Bioinformatics Technology Co., Ltd. has been awarded the 25th China Patent Excellence Award for its invention patent "A Taq DNA Polymerase Mutant Mut4 and Its Application" [1][2] - The award is a recognition of the company's technological innovation capabilities and intellectual property efforts, which will help enhance its core competitiveness and facilitate the transformation of research and development achievements [2] Patent Details - Patent Name: A Taq DNA Polymerase Mutant Mut4 and Its Application [2] - Patent Number: ZL202010980814.1 [2] - Patent Holder: Nanjing Novogene Bioinformatics Technology Co., Ltd. [2] Application and Impact - The patented technology is based on the company's core platform for protein directed evolution and modification, improving enzyme tolerance and amplification performance for high-concentration blood samples [2] - The technology has broad applications in high-throughput sequencing, food safety testing, animal inspection and quarantine, and medical diagnostic testing [2] - The award will not have a significant impact on the company's recent performance [2]